External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

CHDI 2021

-
Coming soon
11:40 AM
Duration 40mins Virtual
Preliminary results from GENERATION HD1, a Phase III trial of tominersen in individuals with manifest Huntington’s disease
Scott Schobel

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar